The largest database of trusted experimental protocols

Nepa21 type 2

Manufactured by Nepa Gene
Sourced in Japan

The NEPA21 Type II is a laboratory equipment product designed for electroporation applications. It is capable of delivering precise and controlled electrical pulses to facilitate the transfer of molecules, such as DNA or RNA, into cells. The device's core function is to provide a reliable and efficient means of performing electroporation experiments in a laboratory setting.

Automatically generated - may contain errors

17 protocols using nepa21 type 2

1

Modulating miR-3646 Levels: Cellular Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To manipulate the cellular levels of miR-3646, 1×106 cells were mixed with miR-3646 mimics at a final concentration of 10nM or antisense inhibitors at 50nM in 100ul culture medium without serum and penicillin-streptomycin. The mixtures were added into pulse cuvettes, and electroporated by Super Electroporator NEPA 21 Type II (poring pulse: pulse voltage, 125V; pulse length, 5ms; pulse interval, 50ms; NEPAGENE, Chiba, Japan). Then, the mixtures (include 5×105 cells) were rapidly plated onto 6-well plate with 2ml of complete medium per well. The transfection efficiency was determined by green fluorescence.
After transfection, the cells were plated at a density of 8×104 /ml into 96-well culture plate with 100μl of complete medium per well and cultured for 24h. The cells were treated with serial dilutions of Doc for 48h. For the drug cytotoxic assays, 20μl of a 5mg/ml solution of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium-bromide (MTT; Sigma, Germany) was added to the cells and incubated for 4h, and then 150μl of dimethyl sulfoxide (DMSO, Amresco, America) was added, and thoroughly mixed to ensure cell lysis. CliniBio128 (ASYS-Hitech, Austria) was used to measure the absorbance at 490nm. Three independent experiments were performed, and the IC50 value of Doc was calculated using SPSS 16.0.
+ Open protocol
+ Expand
2

Electroporation of Jurkat Cells with mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Jurkat cells were resuspended in Opti-MEM (1.11 × 107 cells/µL, 90 µL). An mRNA solution was diluted in Opti-MEM (0.2 µg/µL, 10 µL). The mRNA solution was then added to the cell suspension and set to an electroporator NEPA21 Type II (Nepa Gene Co., Ltd., Chiba, Japan). The electroporation was conducted at a Pp (poring pulse) of 175 V; a Pp duration of 2.5 ms; a Pp interval of 50 ms; a Pp frequency of 2 times; a Pp decay rate of 10%; a Tp (Transfer pulse) of ±20 V; a Tp duration of 50 ms; a Tp interval of 50 ms; a Tp frequency of 5 times for ± Voltage; a Tp decay rate of 40%. Immediately after the electric pulses, the cells were collected by adding 300 µL of culture media. The cells were incubated for 1 h at 37 °C in the CO2 incubator. After the recovery culture, the cells were collected by centrifugation (4 °C, 500× g, 3 min), and then resuspended at a concentration of 1 × 105 cells/mL in culture media containing serum. The cells were transferred to 3.5 cm dishes (1 × 105 cells/mL, 2 mL).
+ Open protocol
+ Expand
3

Electroporation of Embryonic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stage 4 embryos collected on a filter paper ring were electroporated in a custom-made electroporation chamber using the SuperElectroporator NEPA21 type II® (NEPAGENE) with two 5ms poring pulses of 15V, 50ms delay, and three 50ms transfer pulses of 10V, 500ms delay. Solutions of plasmid DNA were prepared as previously described [53 (link)] with a final DNA concentration of 1 μg/μl. Embryos were then cultured ex ovo for up to 48h, harvested and fixed in 4% formaldehyde for 2h at room temperature.
+ Open protocol
+ Expand
4

Silencing ELF3 in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interfering RNA (siRNA) against human ELF3 (siELF3 #1: D‐016080‐01, siELF3 #2: D‐016080‐17, siELF3 pool: M‐016080‐01) and nontargeting siRNA pool (siNC: D‐001206‐14) were purchased from Dharmacon. Cells were transfected with 5‐100 nM siRNA using lipofectamine RNAiMAX (Thermo Fisher Scientific) for DMS53 and ECC4 cells according to the manufacturer's instructions or via electroporation using NEPA21 type II (NEPA GENE Co. Ltd.) for A99 cells with a poring pulse voltage of 150 V and poring pulse width of 5 ms.
+ Open protocol
+ Expand
5

Transgenesis in Common Marmoset Embryos

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmids and mRNA transposases for transgenesis were dissolved in OPTI-MEM (Thermo Fisher Scientific, Inc.). The embryos were transferred to M2 medium containing 0.1 M sucrose (Nacalai Tesque). The plasmids and mRNA were injected into the perivitelline space of embryos using an injection pipette with a spike (TPC, Målov, Denmark), followed by electroporation of the embryos in OPTI-MEM (S2 Table) using a Super Electroporator NEPA21 Type II (NEPA GENE, Chiba, Japan) and platinum plate electrodes on a glass slide (1 mm gap, L 15 mm× W 1 mm × H 1.5 mm). The embryos were incubated in M2 medium for 10 min at room temperature. For common marmosets, embryos were cultured in sequential blast medium for 7–14 days. After cultivation, the embryos were used for subsequent experiments.
+ Open protocol
+ Expand
6

CRISPR Correction of DMD Exon 55

Check if the same lab product or an alternative is used in the 5 most similar protocols
We designed each single guide RNA (sgRNA) sequence upstream and downstream of exon 55 to change “out of frame” to “in frame” via non-homologous end joining (NHEJ) in DMD-iPSCs. The pX459 vector (Addgene, plasmid #48139)42 (link) encoding these sgRNAs were amplified in DH5α competent cells. Two sgRNAs were co-transfected into DMD-iPSCs via electroporation (NEPA21 type II, NepaGene). Co-transfected DMD-iPSCs were purified by puromycin selection and single colony picking. The sgRNA sequences are shown in Supplemental Table 1.
+ Open protocol
+ Expand
7

Generation of Tbx5 and Isl1 Knockout ESC Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the generation of Tbx5 KO vector, sgRNAs were designed with the CRISPR design tool, Benchling (www.benchling.com). In case of Isl1, sgRNAs were used as described previously33 (link). The used sequences of sgRNAs are as follows: Tbx5 sgRNA1: 5′CGAAACCTGAGAGTGCTCTG, Tbx5 sgRNA2: 5′CAAGTCTCCATCATCCCCGC, Isl1 sgRNA1: 5′CCGATTTAAGCCGGCGGAGT, and Isl1 sgRNA2: 5′TCATGAGCGCATCTGGCCGA. Each sgRNA was annealed and inserted into the pGuide-it-ZsGreen1 Vector (Guide-it CRISPR/Cas9 system (Green), Clontech) as per the manufacturer’s protocol. Both of pGuide-it-ZsGreen1-sgRNA1 and -sgRNA2 for each gene were transfected to wild-type (WT) B6 ES cells by electroporation using Super electroporator NEPA 21 typeII (NEPA GENE). To subclone KO cell lines, GFP-positive ES colonies were randomly picked and propagated. All subclones were investigated for their mutations using Guide-it mutation detection kit (Clontech). Six lines of Tbx5 KO ESC lines and six lines of Isl1 KO ESC lines were established and each of the three KO ESC lines were used for the generation of heart organoids with FGF4 on LN/ET complex.
+ Open protocol
+ Expand
8

siRNA Transfection Protocol for BIM Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNA pools were obtained from Horizon Discovery Group (Cambridge, UK). The following ON-TARGETplus siRNA pools were used: non-targeting control (siNC): D-001810-10-05 and siBCL2L11 (siBIM): L-004383-00-0005. siRNAs were transfected into cells by electroporation using NEPA21 TypeII (Nepa Gene Co., Ltd., Chiba, Japan).
+ Open protocol
+ Expand
9

Gene Delivery to Mouse Skeletal Muscle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid DNAs were introduced into mouse gastrocnemius muscle by electroporation as previously described [16 (link),20 (link)]. Mice were anesthetized by intraperitoneal injection of a solution of medetomidine (0.3 mg/kg of body weight), midazolam (4.0 mg/kg of body weight), and butorphanol (5.0 mg/kg of body weight). A combination of expression plasmids (pCAGGS-GLUT4myc7-GFP, pCAGGS-Myr-Akt2-HA×3, pCAGGS-HA×2-FLJ68ΔN, pCAGGS-HA×3-Rac1(G12V), and pCAGGS-HA×3-RalA(G23V)) (80 µg in total) were dissolved in 50 µL of 9 mg/mL NaCl and injected longitudinally into gastrocnemius muscle with a 27-gauge needle. A pair of stainless steel electrode needles fixed 5 mm apart were then inserted into the muscle belly, and square wave electrical pulses (50 milliseconds) were applied three times (100 V, 90 V, and 81 V, respectively) at 100-millisecond intervals (for poring) using a pulse generator (NEPA21 Type II, Nepa Gene (Ichikawa, Japan)). Subsequently, square wave electrical pulses (50 milliseconds) were applied three times (20 V, 12 V, and 7.2 V, respectively) at 100-millisecond intervals, followed by three more pulses under the same conditions except that the polarity is opposite (for transfer).
+ Open protocol
+ Expand
10

Microglia RNA Extraction and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RNAs of primary microglia and the BV-2 cells were extracted using Isogen (Nippon Gene). The cDNAs were synthesized from the extracted RNAs using oligo (dT)15 and reverse transcriptase (Toyobo) reactions.
Murine CX3CR1 and taurine transporter TauT (as a negative control) were cloned and added to the pCAGGS vector (provided by Dr. Miyazaki, Osaka University) with a hemagglutinin (HA) tag. For transfection, 1 × 106 cells were electroporated with 10 μg of plasmids using an electroporator NEPA21 Type II according to the manufacturer’s instructions (NEPA Gene).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!